Novocure's GAAP loss for 3 months of 2022 was $4.647 million, up 12.6% from $4.128 million in the prior year. Revenue increased 2.1% to $137.547 million from $134.695 million a year earlier.
Novocure's GAAP loss for 3 months of 2022 was $4.647 million, up 12.6% from $4.128 million in the prior year. Revenue increased 2.1% to $137.547 million from $134.695 million a year earlier. 
novocure.com
English (US) 